Apatinib Mesylate
≥99%
- Product Code: 135395
CAS:
1218779-75-9
Molecular Weight: | 493.58 g./mol | Molecular Formula: | C₂₅H₂₇N₅O₄S |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | Room temperature, dry, sealed |
Product Description:
Used in targeted cancer therapy, particularly for advanced gastric and hepatocellular carcinomas. Inhibits angiogenesis by selectively blocking vascular endothelial growth factor receptor-2 (VEGFR-2), reducing tumor blood supply and growth. Shows efficacy in patients who have failed prior chemotherapy regimens. Investigated in combination with immunotherapies and other anticancer agents to enhance treatment outcomes. Administered orally, allowing for convenient outpatient use in prolonged treatment plans.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
5mg | 10-20 days | $387.92 |
+
-
|
25mg | 10-20 days | $796.50 |
+
-
|
100mg | 10-20 days | $1,772.65 |
+
-
|
bulk | 10-20 days | $0.00 |
+
-
|
Apatinib Mesylate
Used in targeted cancer therapy, particularly for advanced gastric and hepatocellular carcinomas. Inhibits angiogenesis by selectively blocking vascular endothelial growth factor receptor-2 (VEGFR-2), reducing tumor blood supply and growth. Shows efficacy in patients who have failed prior chemotherapy regimens. Investigated in combination with immunotherapies and other anticancer agents to enhance treatment outcomes. Administered orally, allowing for convenient outpatient use in prolonged treatment plans.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
$0.00
$0.00
Total :